Author

Siri Mjaaland 1

1 Norwegian Institute of Public Health, Oslo, Norway

​FOUR SARS-COV-2 VACCINE DOSES OR HYBRID IMMUNITY IN PATIENTS WITH IMMUNE-MEDIATED INFLAMMATORY DISEASES ON IMMUNOSUPPRESSIVE THERAPIES. A PROSPECTIVE, OBSERVATIONAL COHORT STUDY

Kristin H Bjørlykke, Hilde S. Ørbo, Anne T. Tveter, Trung T. Tran, Joseph Sexton, Ingrid Jyssum, Ingrid E. Christensen, Grete Kro, Tore K Kvien, Jørgen Jahnsen, Ludvig A. Munthe, Adity Chopra, David J. Warren, Gunnveig Grødeland, Espen A Haavardsholm, Siri Mjaaland, Sella A. Provan, John T. Vaage, Silje W. Syversen, Guro

IMMUNOGENICITY AND SAFETY OF A THREE-DOSE SARS-COV-2 VACCINATION STRATEGY IN PATIENTS WITH IMMUNE-MEDIATED INFLAMMATORY DISEASES ON IMMUNOSUPPRESSIVE THERAPY

Kristin Hammersbøen Bjørlykke, Ingrid Jyssum, Anne Therese Tveter, Joseph Sexton, Ingrid E. Christensen, Trung T. Tran, Siri Mjaaland, David J. Warren, Tore K Kvien, Adity Chopra, Grete Birkeland Kro, Jørgen Jahnsen, Ludvig A. Munthe, Espen A Haavardsholm, Gunnveig Grødeland, John Torgils Vaage, Sella Aarrestad Provan, Gur

Item 1 - 2 / 2
1